STK31 maintains the undifferentiated state of colon cancer cells

Carcinogenesis

Volumn 33, Issue 11, 2012, Pages 2044-2053

  Fok, Kin Lam ^a   Chung, Chin Man ^a   Yi, Shao Qiong ^b   Jiang, Xiaohua ^a   Sun, Xiao ^a   Chen, Hao ^a,c   Chen, Yang Chao ^a   Kung, Hsiang Fu ^a   Tao, Qian ^a   Diao, Ruiying ^a,c   Chan, Henry ^d   Zhang, Xiao Hu ^a   Chung, Yiu Wa ^a   Cai, Zhiming ^c   Chang Chan, Hsiao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE 31; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CARCINOGENICITY; CELL DIFFERENTIATION; COLON CANCER; CONTROLLED STUDY; FLOW CYTOMETRY; GENE DELETION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; UNDIFFERENTIATED CARCINOMA;

ADENOCARCINOMA; ANIMALS; BLOTTING, WESTERN; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLON; COLONIC NEOPLASMS; DNA METHYLATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED NOD; MICE, NUDE; MICE, SCID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RNA, SMALL INTERFERING; TISSUE ARRAY ANALYSIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84868615946     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs246     Document Type: Article

References (43)

1. Ichim, C.V. et al. (2006) First among equals: the cancer cell hierarchy. Leuk. Lymphoma, 47, 2017-2027.
2. Heppner, G.H. (1984) Tumor heterogeneity. Cancer Res., 44, 2259-2265.
3. Marusyk, A. et al. (2010) Tumor heterogeneity: causes and consequences. Biochim. Biophys. Acta, 1805, 105-117.
4. Brattain, M.G., et al. (1984) Heterogeneity of human colon carcinoma. Cancer Metastasis Rev., 3, 177-191.
5. Dexter, D.L., et al. (1981) Heterogeneity of cancer cells from a single human colon carcinoma. Am. J. Med., 71, 949-956.
6. Dalerba, P. et al. (2011) Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat. Biotechnol., 29, 1120-1127.
7. Vermeulen, L. et al. (2008) Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc. Natl. Acad. Sci. U.S.A., 105, 13427-13432.
8. Sancho, E. et al. (2004) Signaling pathways in intestinal development and cancer. Annu. Rev. Cell Dev. Biol., 20, 695-723.
9. He, X.C. et al. (2004) BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat. Genet., 36, 1117-1121.
10. Ricci-Vitiani, L. et al. (2008) Colon cancer stem cells. Gut, 57, 538-548.
11. Baselga, J. (2006) Targeting tyrosine kinases in cancer: the second wave. Science, 312, 1175-1178.
12. Krause, D.S. et al. (2005) Tyrosine kinases as targets for cancer therapy. N. Engl. J. Med., 353, 172-187.
13. Wang, P.J. et al. (2001) An abundance of X-linked genes expressed in spermatogonia. Nat. Genet., 27, 422-426.
14. Yokoe, T. et al. (2008) Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis. Cancer Res., 68, 1074-1082.
15. Ho, S.N. et al. (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene, 77, 51-59.
16. Lee, T.L. et al. (2009) GermSAGE: a comprehensive SAGE database for transcript discovery on male germ cell development. Nucleic Acids Res., 37, D891-D897.
17. Bao, J. et al. (2011) STK31(TDRD8) is dynamically regulated throughout mouse spermatogenesis and interacts with MIWI protein. Histochem. Cell Biol., 137, 377-389.
18. Ding, Q.M. et al. (1998) Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4. Am. J. Physiol, 275, C1193-C1200.
19. Cohen, E. et al. (1999) Induced differentiation in HT29, a human colon adenocarcinoma cell line. J. Cell Sci., 112, 2657-2666.
20. Chung, Y.S. et al. (1985) Effect of growth and sodium butyrate on brush border membrane-associated hydrolases in human colorectal cancer cell lines. Cancer Res., 45, 2976-2982.
21. Tsao, D. et al. (1982) Differential effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on membrane-associated antigen, enzymes, and glycoproteins of human rectal adenocarcinoma cells. Cancer Res., 42, 1052-1058.
22. Odoux, C. et al. (2008) A stochastic model for cancer stem cell origin in metastatic colon cancer. Cancer Res., 68, 6932-6941.
23. Yedgar, S. et al. (1992) Cyclic AMP-independent secretion of mucin by SW1116 human colon carcinoma cells. Differential control by Ca2+ ionophore A23187 and arachidonic acid. Biochem. J., 283, 421-426.
24. Chantret, I. et al. (1988) Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. Cancer Res., 48, 1936-1942.
25. Mariadason, J.M. et al. (2000) Divergent phenotypic patterns and commitment to apoptosis of Caco-2 cells during spontaneous and butyrate-induced differentiation. J. Cell Physiol, 183, 347-354.
26. Akare, S. et al. (2006) Ursodeoxycholic acid modulates histone acetylation and induces differentiation and senescence. Int. J. Cancer, 119, 2958-2969.
27. Jordan, C.T. et al. (2006) Cancer stem cells. N. Engl. J. Med., 355, 1253-1261.
28. Capra, M. et al. (2006) Frequent alterations in the expression of serine/ threonine kinases in human cancers. Cancer Res., 66, 8147-8154.
29. Scapin, G. (2002) Structural biology in drug design: selective protein kinase inhibitors. Drug Discov. Today, 7, 601-611.
30. Simpson, A.J. et al. (2005) Cancer/testis antigens, gametogenesis and cancer. Nat. Rev. Cancer, 5, 615-625.
31. Mithraprabhu, S. et al. (2009) Control of KIT signalling in male germ cells: what can we learn from other systems? Reproduction, 138, 743-757.
32. Ohta, H. et al. (2003) Proliferation and differentiation of spermatogonial stem cells in the w/wv mutant mouse testis. Biol. Reprod., 69, 1815-1821.
33. Hemesath, T.J. et al. (1998) MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature, 391, 298-301.
34. Chian, R. et al. (2001) Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant. Blood, 98, 1365-1373.
35. Plo, I. et al. (2001) Kit signaling and negative regulation of daunorubicin-induced apoptosis: role of phospholipase Cgamma. Oncogene, 20, 6752-6763.
36. Ning, Z.Q. et al. (2001) STAT3 activation is required for Asp(816) mutant c-Kit induced tumorigenicity. Oncogene, 20, 4528-4536.
37. Bellone, G. et al. (2001) Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential. Cancer Res., 61, 2200-2206.
38. Hardwick, J.C. et al. (2008) Bone morphogenetic protein signalling in colorectal cancer. Nat.Rev.Cancer, 8, 806-812.
39. Itman, C. et al. (2008) SMAD expression in the testis: an insight into BMP regulation of spermatogenesis. Dev. Dyn., 237, 97-111.
40. Daly, A.C. et al. (2008) Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol. Cell Biol., 28, 6889-6902.
41. Freudenberg, J.A. et al. (2007) Induction of Smad1 by MT1-MMP contributes to tumor growth. Int. J. Cancer, 121, 966-977.
42. Wicha, M.S. et al. (2006) Cancer stem cells: an old idea-a paradigm shift. Cancer Res., 66, 1883-1890.
43. Visvader, J.E. et al. (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer, 8, 755-768.